Yuko Shirouchi

8PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyTumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 02, 2026
Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

|Apr 14, 2026
Extracellular Vesicle IL5RA and BCMA in Serum Enable Non-Invasive Risk Stratification of Multiple Myeloma.

Yuko Shirouchi, Hiroki Shinchi, Yoshimi Haga

|Mar 31, 2026
Isatuximab induces antitumor activity in blastic plasmacytoid dendritic cell neoplasm through cellular cytotoxicity.

Nobuhiko Yamauchi, Yuko Mishima, Tomoko Takayama

|Oct 09, 2025
Recent advances and future perspectives in frontline treatment of peripheral T-cell lymphoma.

Yuko Shirouchi, Nobuhiko Yamauchi, Dai Maruyama

|Aug 23, 2024
Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents.

Yuko Shirouchi, Kazumi Kaihara, Tsunaki Sekita

|Jan 06, 2024
Recent advances and future perspectives of T-cell engagers in lymphoid malignancies.

Yuko Shirouchi, Dai Maruyama

Pageof 2

Frequent Collaborators

5 joint publications

Dai Maruyama

2 joint publications

Hideki Uryu

1 joint publications

Yuka Morita

1 joint publications

Kengo Takeuchi